Global Blood Collection Devices Market, By Product (Blood Collection Tubes, System Type, Needles and Syringes, Blood Bags, Blood Collection Systems/Monitors, and Lancets), Method (Manual Blood Collection, and Automated Blood Collection), Application (Diagnostics, and Therapeutic), End-User (Hospital, Blood Bank Center, Academics, and Home Care) – Industry Trends and Forecast to 2031.
Blood Collection Devices Market Analysis and Size
The blood collection devices market is witnessing exponential growth, driven by the integration of the latest technology. Innovations such as advanced needle designs, painless extraction techniques, and enhanced safety features are revolutionizing the industry. These advancements not only improve patient experience but also streamline healthcare processes, leading to increased efficiency and accuracy in blood collection procedures.
The global blood collection devices market size was valued at USD 6.50 billion in 2023, is projected to reach USD 10.48 billion by 2031, with a CAGR of 6.16% during the forecast period 2024 to 2031. This indicates that the market value. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Years
|
2022 (Customizable to 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Blood Collection Tubes, System Type, Needles and Syringes, Blood Bags, Blood Collection Systems/Monitors, and Lancets), Method (Manual Blood Collection, and Automated Blood Collection), Application (Diagnostics, and Therapeutic), End-User (Hospital, Blood Bank Center, Academics, and Home Care)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Abbott (U.S.), Medtronic (Ireland), BD (U.S.), Terumo Corporation (Japan), NIPRO Corporation (Japan), QIAGEN (Germany), Medical s.r.l. (Italy), TERUMO BCT, INC. (U.S.), Fresenius Kabi AG (Germany), Grifols, S.A. (Spain), Micsafe SARSTEDT AG & Co. KG (Germany), Retractable Technologies, Inc. (U.S.), FL MEDICAL s.r.l. Unipersonale (Italy), and AB Medical Academy (Netherlands)
|
|
Market Opportunities
|
|
Market Definition
Blood collection devices are specialized tools used in medical settings to draw blood samples from patients for diagnostic testing or donation purposes. These devices include syringes, vacuum tubes, lancets, and needles, designed to ensure sterile and safe blood extraction while minimizing patient discomfort. Proper use of these devices is crucial for accurate test results and patient well-being in healthcare practices.
Blood Collection Devices Market Dynamics
Drivers
- Increasing Incidence of Chronic Diseases
The escalating incidence of chronic illnesses such as diabetes, cancer, and cardiovascular diseases necessitates frequent blood testing, propelling the demand for blood collection device. For instance, the increasing prevalence of diabetes worldwide leads to a growing need for glucose monitoring, driving the demand for blood collection tools compatible with glucose meters, lancets, and test strips, thereby fueling market growth.
- Rise in Blood Donation Activities
The surge in blood donation activities, spurred by heightened awareness and government and healthcare organization initiatives, propels the demand for blood collection devices in blood banks and donation centers. For instance, campaigns promoting regular blood donations have led to a substantial increase in donors, necessitating efficient collection methods. Consequently, manufacturers are innovating to meet the rising demand for reliable, safe, and high-throughput blood collection devices, driving market growth.
Opportunities
- Expansion of Healthcare Infrastructure
The expansion and modernization of healthcare infrastructure, particularly in developing regions, present significant opportunities for blood collection device manufacturers to penetrate new markets and drive overall market growth. For instance, the establishment of new hospitals, clinics, and blood banks in regions with previously limited access to healthcare services creates a demand for advanced blood collection devices to support diagnostic and therapeutic procedures, thus fostering market expansion and development.
- Rising Demand for Point-of-Care Testing (POCT)
The increasing demand for point-of-care testing (POCT) presents a significant market opportunity, driven by its convenience and swift results. Blood collection devices compatible with POCT, such as handheld lancets and capillary blood collection devices, enable healthcare professionals to swiftly collect samples at the patient's bedside or in remote locations. This expedited process accelerates diagnosis and treatment decisions, enhancing patient care and driving market growth.
Restraints/Challenges
- Rising Concerns Regarding Contamination and Infection
Concerns regarding contamination and infection hinder the blood collection devices market by raising apprehensions about safety and hygiene. Instances of contamination can lead to serious health risks for patients, eroding trust in the reliability of these devices. This undermines market growth as healthcare providers and patients seek alternatives perceived as safer.
- Competition from Alternative Technologies
Competition from alternative technologies such as saliva or urine-based tests presents a formidable challenge to traditional blood collection methods, potentially hindering market growth. Manufacturers face the pressure to innovate in order to differentiate their products and retain market share against these emerging alternatives, which offer less invasive and more convenient diagnostic options.
This market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In March 2022, Terumo Blood and Cell Technologies gained FDA approval for Rika Plasma Donation System (Rika), featuring advanced automation and safety measures, collecting plasma in 35 minutes or less, reducing operator errors
- In February 2022, Abacus dx introduced RNA Complete BCT by Streck, enhancing blood sample collection, transport, and storage convenience with their latest addition to the tube portfolio
- In July 2021, BD obtained FDA Emergency Use Authorization for BD Vacutainer plus Citrate Plasma Tubes, facilitating coagulation testing by efficiently collecting, transporting, and storing blood specimens with sodium citrate tubes
Blood Collection Devices Market Scope
The market is segmented on the basis of product, method, application, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Blood Collection Tubes
- Plasma/Whole-Blood Tubes
- EDTA Tubes
- Heparin Tubes
- Coagulation Tubes
- Glucose Tubes
- ESR Tubes
- Serum Tubes
- Plasma/Whole-Blood Tubes
- System Type
- Vacuum Tubes
- Non-Vacuum Tubes
- Needles and Syringes
- Blood Bags
- Blood Collection Systems/Monitors
- Lancets
Method
- Manual Blood Collection
- Automated Blood Collection
Application
- Diagnostics
- Therapeutic
End-User
- Hospital
- Blood Bank Center
- Academics
- Home Care
Blood Collection Devices Market Regional Analysis/Insights
The market is analysed and market size insights and trends are provided by country, product, method, application, and end-user as referenced above.
The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific is estimated to witness the highest growth in the blood collection devices market, attributed to rising disposable income, expanding presence of key manufacturers, and increasing prevalence of sepsis and healthcare-associated infections (HAI) in the region. These factors drive demand for advanced blood collection technologies and devices.
North America is expected to dominate the blood collection devices market due to increasing research, robust healthcare infrastructure, emphasis on clinical trials, and consumer adoption of innovative technology. These factors position the region as a leader in advancing blood collection techniques and technologies.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the market. The data is available for historic period 2016-2021.
Competitive Landscape and Blood Collection Devices Market Share Analysis
The market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to market.
Some of the major players operating in the market are:
- Abbott (U.S.)
- Medtronic (Ireland)
- BD (U.S.)
- Terumo Corporation (Japan)
- NIPRO Corporation (Japan)
- QIAGEN (Germany)
- Medical s.r.l. (Italy)
- TERUMO BCT, INC. (U.S.)
- Fresenius Kabi AG (Germany)
- Grifols, S.A. (Spain)
- Micsafe SARSTEDT AG & Co. KG (Germany)
- Retractable Technologies, Inc. (U.S.)
- FL MEDICAL s.r.l. Unipersonale (Italy)
- AB Medical Academy (Netherlands)
SKU-